期刊文献+

表达H5N1亚型禽流感病毒HA蛋白重组新城疫病毒的构建以及密码子优化的HA免疫增强作用 被引量:4

Construction of recombinants Newcastle disease virus expressing H5N1 subtypes avian influenza virus HA protein and the enhance protection by optimized-codons
下载PDF
导出
摘要 为构建表达H5N1亚型禽流感病毒(AIV)HA蛋白重组新城疫病毒(NDV)及比较密码子优化的HA免疫增强作用,本研究利用NDV LaSota弱毒疫苗株的反向遗传操作系统,分别构建了表达野毒型H5N1亚型AIV HA蛋白和密码子优化的HA蛋白的重组NDV,并分别命名为rL-H5HA和rL-optiH5HA。对拯救的重组病毒进行RT-PCR、间接免疫荧光和western blot鉴定,结果表明,两种重组病毒均可以在BHK-21细胞中以及鸡胚成纤维细胞稳定地表达HA蛋白。此外,rL-optiH5HA在体外增殖能力及在体内刺激产生抗体均显著高于rL-H5HA。本研究表明,密码子优化的HA重组NDV具有明显的免疫增强作用。本研究为研制安全、有效的新型禽流感疫苗提供了实验依据。 In order to construct a recombinant Newcastle disease virus (NDV) expressing hemagglutinin (HA) of H5N1 subtype avian influenza virus (AIV) and evaluate the ability of enhancement for antibody product by HA with optimized-codons, we constructed and rescued the rL-H5HA and rL-optiH5HA of recombinant NDVs expressing the original HA protein and the codon-optimized H5HA (optiH5HA) protein of the H5N1 subtype AIV GD322 strain, respectively. The identification results showed that the HA proteins were stably expressed form the recombinant virus infected BHK-21 cell and CEF cell detected by RT-PCR, western blot, and indirect immunofluorescence assay. While, the HI titers in chickens immunized with rL-optiH5HA were significantly higher than those chickens immunized with rL-H5HA. These results demonstrated that the rL-optiH5HA had the potential of being used as a life NDV vector based A1V vaccine.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2014年第8期585-589,共5页 Chinese Journal of Preventive Veterinary Medicine
基金 国家自然科学基金(30800816)
关键词 禽流感病毒 HA蛋白 重组新城疫病毒 密码子优化 avian influenza virus HA protein recombinant NDV codon-optimization
  • 相关文献

参考文献8

  • 1Jiang Yong-ping, Tian Guo-bin, Chen Hua-lan, et al.Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector [J].Antiviral Res, 2007, 75: 234-241.
  • 2Romer-Oberdorfer A, Veits J, Helferich D, et al.Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus [J].Vaccine, 2008, 26: 2307-2313.
  • 3Toro H H, Tang D C, Suarez D L, et al.Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine [J].Vaccine, 2008, 26: 2640-2646.
  • 4葛金英,温志远,步志高,等.表达绿色荧光蛋白重组新城疫病毒LaSota疫苗株的构建[J].病毒学报,2007,81:150-158.
  • 5Li Yan-bing, Shi Jian-zhong, Zhong Guo-xun, et al.Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009 [J].J Virol, 2010, 84(17): 8389-8397.
  • 6Ge jin-ying, Wen zhi-yuan, Wang xi-jun, et al.Generating vesicular stomatitis virus pseudotype bearing the severe acute respiratory syndrome coronavirus spike envelope glycoprotein for rapid and safe neutralization test or cell-entry assay [J].Ann N Y Acad Sci, 2006, 1081: 246-248.
  • 7温志远,葛金英,王永,胡森,郝永清,步志高.水泡性口炎病毒印第安纳株反基因操作系统的建立[J].中国预防兽医学报,2006,28(5):489-494. 被引量:10
  • 8Mebatsion T, Verstegen S, De Vaan L T, et al.A recombinant newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos [J].J Virol, 2001, 75(1): 420-428.

二级参考文献20

  • 1Barr J N. Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus [J]. Biochim Biophys Acta, 1577: 337-353.
  • 2Lawson N D , Stillman E A, Whitt M A, et al. Recombinant vesicular stomatitis viruses from DNA [J]. Proc Nat I Acad Sci, 1995, 92: 4477-4481.
  • 3Whelan S J, Ball L A, Barr J N, et al. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones[J].Proc Nat I Acad Sci, 1995, 92: 8388-8392.
  • 4Roberts A, Kretzschmar E, Kawaoka Y , et al.Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge [J]. J Virol, 1998, 72(6): 4704-4711.
  • 5Rose N F. An effect ive AIDS vaccine base d on live attenuated vesicular stomatitis virus recombinants [J ]. Cell, 2001, 106: 539- 549.
  • 6Stojdl D F. VSV strains with defects in their ability to shutdownin nate immunity are potent systemic anti-cancer agents[J]. Cancer Cell, 2003, 4: 263-275.
  • 7Schurer H, Lang K, Schuster J, et al. A universal method to produce in vitro transcripts with homogeneous 3' ends[J].Nucleic Acid Research, 2002, 30: (12) 56.
  • 8Takada A C, Robison H, Goto A, et al. A system for functional analysis of Ebola virus glycoprotein [J]. Proc Natl Acad Sci,1997, 94: 14764-14769.
  • 9Inoue K, Shoji Y, Kurane I, et al. An improved method for recovering rabies virus from cloned cDNA[J]. J Med Virol, 2002,107: 229-236.
  • 10Stillman E A, J K Rose, M A Whitt. Replication and Amplification of Novel Vesicular Stomatitis Virus Minigenomes Encoding Viral Structural Proteins[J]. J Virol, 1995, 69: 2946-2953.

共引文献9

同被引文献26

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部